Publicaciones en las que colabora con Manuel Hidalgo Medina (5)

2015

  1. SPARC expression did not predict efficacy of nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer in an exploratory analysis of the phase III MPACT trial

    Clinical Cancer Research, Vol. 21, Núm. 21, pp. 4811-4818

  2. Whole exome sequencing of rapid autopsy tumors and xenograft models reveals possible driver mutations underlying tumor progression

    PLoS ONE, Vol. 10, Núm. 11

2014

  1. Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer

    Pharmacology Research and Perspectives, Vol. 2, Núm. 6

  2. Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

    British Journal of Cancer

2013

  1. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

    British Journal of Cancer, Vol. 109, Núm. 4, pp. 926-933